Allen Zheng

TL;DR: The results provide evidence that the immunodominance of HA stems in part from its abundance on the viral surface, and that rewiring viral packaging signals—thereby increasing the NA content on viral particles—is a viable strategy for improving the immunogenicity of NA in an influenza virus vaccine.

TL;DR: In this article, a rationale for developing and testing intranasal interferon beta (IFN-β) as an immediately available intervention for new respiratory viral infections that will arise unexpectedly in the future is presented and supported by basic and clinical trial observations.

TL;DR: In this article, the mutated influenza virus neuraminidase polypeptides are defined, and a first-stalk domain of the first-person influenza virus is defined.

TL;DR: Close monitoring of broad-spectrum antibiotic use and antibiotic deescalation should occur if interventions to limit blood culture testing are implemented and interventions should include all providers, including consulting physicians.